Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tanya I. Deneva"'
Autor:
Tanya I. Deneva, Youri P. Ianakiev
Publikováno v:
Folia Medica, Vol 63, Iss 1, Pp 122-128 (2021)
Introduction: Medical profession is a stress factor for the development of burnout, symptoms of anxiety and depression as a result of 24-hour work, delayed work-life balance gratification and challenges associated with patient care. Aim: This study a
Externí odkaz:
https://doaj.org/article/76d23f1243404de4b0976accadadbdc8
Autor:
Elina A. Beleva MD, PhD, Tanya I. Deneva MD, PhD, Snezhana S. Stoencheva MD, Zhanet G. Grudeva-Popova MD, PhD, MPH
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Hemostatic parameters have been investigated as molecular determinants of tumor progression. To analyze the dynamics of microparticle-associated tissue factor activity (MPTF), tissue factor antigen (TF-Ag), and angiopоietin-2 (ANG-2) in cancer patie
Externí odkaz:
https://doaj.org/article/a4f976c5882a49f1ac73df5ee368ad9d
Publikováno v:
Bratislavske lekarske listy. 124(1)
Prothrombotic tendency is characteristic of tumors. The aim of the study is to investigate the changes in the laboratory parameters for coagulation and fibrinolysis, namely in fibrinogen, thrombin-antithrombin complex (ТАТ), tissue factor (ТF), p
Autor:
Tanya I, Deneva, Youri P, Ianakiev
Publikováno v:
Folia medica. 63(1)
Medical profession is a stress factor for the development of burnout, symptoms of anxiety and depression as a result of 24-hour work, delayed work-life balance gratification and challenges associated with patient care.This study aimed to verify the r
Autor:
Tanya I Deneva-Koycheva, Todorka Z Tsvetkova, Lyudmila G Vladimirova-Kitova, Evgenia A Angelova
Publikováno v:
Folia medica. 53(2)
Background: Endothelial dysfunction is increasingly recognized as an important early feature of vascular disease. As the damage to endothelium is a key underlying factor in the development and progression of atherosclerotic processes, markers of endo
Autor:
Evgeniya A. Angelova, Tanya I Deneva-Koycheva, Lyudmila G Vladimirova-Kitova, Todorka Z Tsvetkova
Publikováno v:
Folia Medica. 53
UNLABELLED Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of the endothelial nitric oxide synthase (eNOs). ADMA is believed to be implicated in angiogenesis because it regulates the nitric oxide biosynthesis; any pathologic
Publikováno v:
Vascular pharmacology. 56(3-4)
Research of statin influence on asymmetric dimethylarginine (ADMA) and flow-mediated vasodilatation (FMD) reveals controversial results. The aim of this study was to investigate the effects of moderate (40mg) and high (80mg) simvastatin doses on the